Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib
May 2019
Antithrombotic combos for patients with atrial fib PLUS a coronary stent are a moving target...due to evolving evidence and stent technology.
The standard used to be "triple therapy"...an anticoagulant (warfarin, etc) plus TWO antiplatelets (aspirin and clopidogrel, etc).
But these combos are a tightrope walk...and risk of bleeding must be balanced against risk of embolic stroke, MI, or stent thrombosis.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote